2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in …

PK Whelton, RM Carey, WS Aronow, DE Casey… - Journal of the American …, 2018 - jacc.org
As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-
1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

Diabetes in sub-Saharan Africa: from clinical care to health policy

R Atun, JI Davies, EAM Gale… - The lancet Diabetes & …, 2017 - thelancet.com
Executive summary Rapid demographic, sociocultural, and economic transitions are driving
increases in the risk and prevalence of diabetes and other non-communicable diseases …

Potential US population impact of the 2017 ACC/AHA high blood pressure guideline

P Muntner, RM Carey, S Gidding, DW Jones, SJ Taler… - Circulation, 2018 - Am Heart Assoc
Background: The 2017 American College of Cardiology/American Heart Association
(ACC/AHA) Guideline for the Prevention, Detection, Evaluation and Management of High …

Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged≥ 75 years: a randomized clinical trial

JD Williamson, MA Supiano, WB Applegate… - Jama, 2016 - jamanetwork.com
Importance The appropriate treatment target for systolic blood pressure (SBP) in older
patients with hypertension remains uncertain. Objective To evaluate the effects of intensive …

2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure …

JW McEvoy, CP McCarthy, RM Bruno… - European Heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The epidemiology of blood pressure and its worldwide management

K Rahimi, CA Emdin, S MacMahon - Circulation research, 2015 - Am Heart Assoc
Despite the vast amount of evidence on the benefits of blood pressure lowering
accumulated to date, elevated blood pressure is still the leading risk factor for disease and …

Cost-effectiveness of hypertension therapy according to 2014 guidelines

AE Moran, MC Odden, A Thanataveerat… - … England Journal of …, 2015 - Mass Medical Soc
Background On the basis of the 2014 guidelines for hypertension therapy in the United
States, many eligible adults remain untreated. We projected the cost-effectiveness of treating …

Estimating longitudinal risks and benefits from cardiovascular preventive therapies among medicare patients: the million hearts longitudinal ASCVD risk assessment …

DM Lloyd-Jones, MD Huffman, KN Karmali… - Circulation, 2017 - Am Heart Assoc
The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes—the
leading causes of mortality—through several public health and healthcare strategies by …

Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus

JB Sussman, EA Kerr, SD Saini… - JAMA internal …, 2015 - jamanetwork.com
Importance Older patients with diabetes mellitus receiving medical treatment whose blood
pressure (BP) or blood glucose level are potentially dangerously low are rarely …

Income disparities in absolute cardiovascular risk and cardiovascular risk factors in the United States, 1999-2014

A Odutayo, P Gill, S Shepherd, A Akingbade… - JAMA …, 2017 - jamanetwork.com
Importance Large improvements in the control of risk factors for cardiovascular disease have
been achieved in the United States, but it remains unclear whether adults in all …